Medindia

X

Best Practice Adopted Worldwide From Norway to Australia

Thursday, March 11, 2010 General News J E 4
Advertisement
LONDON, March 11, 2010 Over 100,000 practitioners nowhave access to Best Practice, the latest product from the BMJ EvidenceCentre, which provides information for healthcare professionals at the pointof care. It has been adopted by over 250 institutions in 25 countries acrossEurope, the Middle East and Asia Pacific.

Users range from individual clinicians to national health libraries,medical associations, health care consortia, hospitals and GP practices.Leading adopters include the Australian Medical Association (WesternAustralia) and the Norwegian Electronic Health Library, Helsebiblioteket.

Mr Kjell Tjensvoll, Consortia Manager from the Helsebiblioteket in Norwaysaid:

"Best Practice came out as the best product according to the decisioncriteria in our tender procedure. The criteria were designed to measuretechnical specifications, quality, usability, relevance and availability inaddition to pricing. Our ambition is to present Best Practice as one of thecore reference tools for Norwegian physicians in the years to come."

The President of the Australian Medical Association (Western Australia)said:

"Our members need quick access to reliable up-to-date information whenmaking diagnosis and treatment decisions. Best Practice is a major advance inmeeting this requirement through delivering authoritative information at thepoint of care."

Best Practice brings together the latest research evidence, guidelinesand expert opinion into one simple service which provides trustworthyinformation structured around the patient consultation, covering diagnosis,prognosis, treatment and prevention.

Dr Rubin Minhas, Clinical Director of The BMJ Evidence centre said:

"Already Best Practice is being seen as a major advance in meeting theday to day needs of busy clinicians through delivering authoritativeinformation at the point of care"For more information please contact: Emma Dickinson Tel: +44-(0)20-7383-6529 Email: edickinson@bmjgroup.com

SOURCE BMJ Group
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Big Pharma Insights On a Small Pharma Budget - Piv...
S
RetireSafe Urges All Seniors to Call on Congress t...